Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine

PurposeThe purpose of this study was (1) to explore for socio-demographic factors that could potentially affect the intention of women to vaccinate themselves, their 13-year-old daughter and their 13-year-old son against HPV, and (2) to investigate the main reasons for declining vaccination.MethodsA structured questionnaire was used in participants of the project (N = 5,249). Logistic regression analysis was applied in order to examine the correlation between vaccine acceptability and a list of potential predictors. In women declining vaccination, the reported reasons for decline were analyzed.ResultsResidence in rural areas and low to medium tiers of family income were the most constant factors in favor of intention to vaccinate. Receiving information from a healthcare professional was found to positively affect vaccine acceptability for the woman herself, but it did not affect her intention to vaccinate her daughter or her son. The acceptance rates decreased significantly after the vaccine became available, both for the women themselves and for their daughters or sons. During the same year, a shift was noted in the reason for declining vaccination; the self-perception of insufficient knowledge significantly decreased and the fear of adverse effects significantly increased in all three cases.ConclusionApart from demographic factors which may favor or disfavor vaccine acceptability, the intention to vaccinate decreased significantly and the proportion of women rejecting vaccination for safety concerns increased significantly after the introduction of the vaccine, coinciding with isolated cases of negative publicity and highlighting the potential of misinformation by the media.

[1]  P. Sparén,et al.  Acceptability of HPV vaccination among young adults aged 18-30 years--a population based survey in Sweden. , 2010, Vaccine.

[2]  A. Shefer,et al.  Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. , 2009, Preventive medicine.

[3]  M. Petticrew,et al.  Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008) , 2010, Social Science & Medicine.

[4]  Giannoula D. Bakogianni,et al.  HPV vaccine acceptance among female Greek students , 2010, International journal of adolescent medicine and health.

[5]  G. Bae,et al.  Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate. , 2010, Vaccine.

[6]  G. Krogh,et al.  High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up , 2006, British Journal of Cancer.

[7]  G. Zimet,et al.  Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. , 2009, Journal of women's health.

[8]  D. Bernstein,et al.  Attitudes about human papillomavirus vaccine in young women , 2003, International journal of STD & AIDS.

[9]  S. Jacobsen,et al.  Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. , 2010, American journal of epidemiology.

[10]  N. Khardori Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial , 2009 .

[11]  S. Garland,et al.  Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far. , 2009, Vaccine.

[12]  M Arbyn,et al.  Worldwide burden of cervical cancer in 2008. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  C. Berry-Cabán,et al.  HPV vaccination coverage among adolescents aged 9 to 17 years in a United States military treatment facility , 2009, International journal of adolescent medicine and health.

[14]  G. Zimet,et al.  Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: A Randomized Intervention Study of Written Information About HPV , 2006, Pediatrics.

[15]  K. Ault Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials , 2007, The Lancet.

[16]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[17]  D. Bodurka,et al.  Are women ready for the HPV vaccine? , 2006, Gynecologic oncology.

[18]  M. Watson,et al.  Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia , 2009, Australian and New Zealand journal of public health.

[19]  A. Fleischauer,et al.  Intent to receive influenza A (H1N1) 2009 monovalent influenza vaccines - two counties, North Carolina. , 2009 .

[20]  K. McCaffery,et al.  The domino effect: adolescent girls’ response to human papillomavirus vaccination , 2011, The Medical journal of Australia.

[21]  L. Balluz,et al.  Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. , 2010, MMWR. Morbidity and mortality weekly report.

[22]  T. Weiss,et al.  Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women , 2010, BMC women's health.

[23]  J. Löwer [Two unclear cases of death. Can we still recommend HPV vaccination?]. , 2008, MMW Fortschritte der Medizin.

[24]  B. Brumback,et al.  Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. , 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[25]  D. Bernstein,et al.  Viral Sexually Transmitted Disease Vaccine Acceptability Among College Students , 2003, Sexually transmitted diseases.

[26]  K. Wilson,et al.  An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs. , 2010, Vaccine.

[27]  M Quinn,et al.  Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. , 1999, BMJ.

[28]  M. Schootman,et al.  Geographic disparity, area poverty, and human papillomavirus vaccination. , 2010, American journal of preventive medicine.

[29]  D. Hoover,et al.  Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. , 2000, Health care for women international.

[30]  David N Durrheim,et al.  Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public , 2010, The Medical journal of Australia.

[31]  J. Klosky,et al.  Factors influencing familial decision-making regarding human papillomavirus vaccination. , 2010, Journal of pediatric psychology.

[32]  P C Prorok,et al.  Evaluation of screening programmes for gynaecological cancer. , 1985, British Journal of Cancer.

[33]  R. Rouzier,et al.  Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches. , 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[34]  J. Fielding,et al.  Human papillomavirus vaccine among adult women: disparities in awareness and acceptance. , 2010, American journal of preventive medicine.

[35]  J. Stryker,et al.  The HPV vaccine: a content analysis of online news stories. , 2009, Journal of women's health.

[36]  M. Ruffin,et al.  Worsening disparities in HPV vaccine utilization among 19-26 year old women. , 2011, Vaccine.

[37]  Key W Ords Attitudes, Intentions, and Perceived Barriers to Human Papillomavirus Vaccination Among Korean High School Girls and Their Mothers , 2011 .